Loading…
3B Blackbio Dx (3BBLACKBIO)₹1,294+1.39%Healthcare Service Provider
At the end of the Jun 2026 quarter, 3B Blackbio Dx's shareholders were: promoters 40.94%, FIIs 2.51%, DIIs 2.14%, public 54.41%. Promoter holding is up 0.01 percentage points from 40.93% a quarter earlier. FII holding is down 0.20 percentage points from 2.71% a year earlier. It had 11,047 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 38.42% | 38.42% | 41.28% | 41.27% | 41.27% | 41.27% | 41.27% | 41.27% | 41.27% | 41.26% | 40.93% | 40.94% |
| FIIs | 3.18% | 3.40% | 2.99% | 3.30% | 3.29% | 2.69% | 2.50% | 2.71% | 2.65% | 2.58% | 2.58% | 2.51% |
| DIIs | 0.82% | 1.17% | 1.88% | 1.95% | 1.95% | 1.73% | 1.59% | 1.75% | 1.81% | 1.86% | 1.97% | 2.14% |
| Public | 57.58% | 57.01% | 53.85% | 53.48% | 53.49% | 54.31% | 54.64% | 54.27% | 54.27% | 54.30% | 54.52% | 54.41% |
| Number of shareholders | 10,511 | 10,086 | 9,752 | 9,398 | 9,585 | 10,164 | 10,343 | 10,617 | 10,707 | 10,505 | 10,614 | 11,047 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Mithla Dubey | Promoter | 12.40% | 0.00 |
| Mithala Laboratories Private Limited | Promoter | 9.53% | 0.00 |
| Dhirendra Dubey | Promoter | 8.43% | +0.01 |
| Rashi Daga | Public | 5.63% | +0.09 |
| Prateek Goel | Public | 5.12% | 0.00 |
| Own Infracon Private Limited | Public | 4.37% | 0.00 |
| Nikhil Kuber Dubey | Promoter | 4.16% | 0.00 |
| Maj Navraj Singh Grewal | Public | 2.67% | +0.05 |
| 2B Blackbio S.L. Spain | Promoter | 2.49% | 0.00 |
| Ram Kuber Dhirendra Kumar | Promoter | 2.29% | 0.00 |
| Ark Global Emerging Companies Lp | FII | 1.93% | 0.00 |
| Dalmus Performance Focused Fund | DII | 1.86% | 0.00 |
| Investor Education And Protection Fund A | Public | 1.24% | −0.01 |
| Shalu Aggarwal | Public | 1.05% | 0.00 |
| Sandeep Kapadia | Public | 0.99% | 0.00 |
| Rajesh Kumar Dubey | Promoter | 0.44% | 0.00 |
| Madhulika Dubey | Promoter | 0.34% | 0.00 |
| Santosh Kumar Dubey | Promoter | 0.31% | 0.00 |
| Mahesh Kumar Upadhyay | Promoter | 0.28% | 0.00 |
| Anamika Dubey | Promoter | 0.26% | 0.00 |
| Sanjay Kumar Dubey | Promoter | 0.06% | 0.00 |
| Prajesh Maroo | Public | Exited | — |
Promoters held 40.94% of 3B Blackbio Dx at the end of the Jun 2026 quarter, down 0.33 percentage points from 41.27% a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 2.51% (down 0.07 percentage points from 2.58% a quarter earlier) and domestic institutions (DIIs) held 2.14% (up 0.17 percentage points from 1.97% a quarter earlier).
3B Blackbio Dx had 11,047 shareholders at the end of the Jun 2026 quarter, against 10,617 a year earlier.
Rashi Daga (Public) held 5.63% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.